NCT03121534 Ibrutinib, Nivolumab and Blinatumomab in Richter Transformation Status TERMINATED Phase PHASE2
NCT03117751 Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT03114865 A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03106051 Study of Apremilast Use in Patients With Psoriatic Arthritic in Practice Conditions Status COMPLETED Phase N/A
NCT03097003 A Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in Belgium Status COMPLETED Phase N/A
NCT03096990 A Study of the Real-life Management of Psoriatic Arthritis Patients Treated With Otezla® (Apremilast) in Belgium Status COMPLETED Phase N/A
NCT03096288 Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity Status COMPLETED Phase PHASE4
NCT03091127 Real-world Use of Carfilzomib Among Multiple Myeloma Patients in Europe Status COMPLETED Phase N/A
NCT03088176 Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma Status UNKNOWN Phase PHASE1
NCT03087851 Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis Status COMPLETED Phase PHASE4
NCT03086642 Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT03080935 Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries Status TERMINATED Phase PHASE3
NCT03072771 Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Status COMPLETED Phase PHASE1
NCT03070002 Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells Status TERMINATED Phase PHASE2
NCT03069378 A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03064763 Study to Evaluate the Safety/ Efficacy of T-VEC in Japanese Subjects With Unresectable Stage IIIB-IV Malignant Melanoma Status COMPLETED Phase PHASE1
NCT03043950 Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI or FOLFOX in First Line (VALIDATE) Status COMPLETED Phase N/A
NCT03029234 Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma Status COMPLETED Phase PHASE3
NCT03023878 Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE2